Cephalon Makes an Offer For Arana | March 9, 2009 Issue - Vol. 87 Issue 10 | Chemical & Engineering News
Volume 87 Issue 10 | p. 15 | Concentrates
Issue Date: March 9, 2009

Cephalon Makes an Offer For Arana

Department: Business

Cephalon has made a $207 million offer to acquire the 80% of Australia’s Arana Therapeutics that it does not already own. Arana develops antibody-based drugs to treat inflammatory diseases and cancer. Its lead candidate, a tumor necrosis factor alpha blocker, is in Phase II trials for both psoriasis and rheumatoid arthritis. The company also receives royalties from Abbott Laboratories and Johnson & Johnson for technology licenses. Arana’s independent directors are recommending that shareholders accept the deal in the absence of a better proposal.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment